Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Goldstein

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
International Journal of Clinical Practice|August 24, 2000
RosiglitazoneB J Goldstein
Psychosomatics|September 1, 1970
Comparative efficacy of thiothixene capsules and concentrate in acutely schizophrenic patientsB J Goldstein
Hospital & Community Psychiatry|February 1, 1982
Interaction of antacids with psychotropicsB J Goldstein
Receptor|January 1, 1993
Regulation of insulin receptor signaling by protein-tyrosine dephosphorylationB J Goldstein
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistanceB J Goldstein
Journal of Cellular Biochemistry|January 1, 1992
Protein-tyrosine phosphatases and the regulation of insulin actionB J Goldstein
Diabetes Technology & Therapeutics|July 28, 2001
Current views on the mechanism of action of thiazolidinedione insulin sensitizersB J Goldstein
Protein Profile|January 1, 1995
Phosphoprotein phosphatases 1: tyrosine phosphatasesB J Goldstein
International Journal of Clinical Practice|July 19, 2006
Closing the gap between clinical research and clinical practice: can outcome studies with thiazolidinediones improve our understanding of type 2 diabetes?B J Goldstein
Journal of Psychopharmacology (Oxford, England)|November 10, 1998
SSRIs in depression: a decade of progressB J Goldstein
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Clinical Practice|August 24, 2000
RosiglitazoneB J Goldstein
Psychosomatics|September 1, 1970
Comparative efficacy of thiothixene capsules and concentrate in acutely schizophrenic patientsB J Goldstein
Hospital & Community Psychiatry|February 1, 1982
Interaction of antacids with psychotropicsB J Goldstein
Receptor|January 1, 1993
Regulation of insulin receptor signaling by protein-tyrosine dephosphorylationB J Goldstein
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistanceB J Goldstein
Journal of Cellular Biochemistry|January 1, 1992
Protein-tyrosine phosphatases and the regulation of insulin actionB J Goldstein
Diabetes Technology & Therapeutics|July 28, 2001
Current views on the mechanism of action of thiazolidinedione insulin sensitizersB J Goldstein
Protein Profile|January 1, 1995
Phosphoprotein phosphatases 1: tyrosine phosphatasesB J Goldstein
International Journal of Clinical Practice|July 19, 2006
Closing the gap between clinical research and clinical practice: can outcome studies with thiazolidinediones improve our understanding of type 2 diabetes?B J Goldstein
Journal of Psychopharmacology (Oxford, England)|November 10, 1998
SSRIs in depression: a decade of progressB J Goldstein
Pageof 15